Introduction: Glycosphingolipids with novel structures and biological implications. When I started learning about the world of glycosphingolipids (GSLs), only a few were known: cerebrosides (discovered by J. L. W. Thudichum), sulfatide (established by G. Blix), gangliosides and lactosylceramide (discovered by E. Klenk), hematoside (discovered by T. Yamakawa), and globoside (presence indicated by E. Klenk; composition and structure elaborated, and so named, by T. Yamakawa).
my previous review, ~25 new structures were listed. 1) Here, in Table I , I list several novel structures of antigenic or functional importance. Blood group ABH antigens are known to be carried by type 1 (Galβ 1-3GlcNAcβ 1-3Galβ 1R) or type 2 (Galβ 1-4GlcNAcβ 1-3Galβ 1R) with various chain lengths and degrees of branching. 2) More recently, novel carriers showing different distribution patterns were discovered. Type 3 chain A or H are A-on-A (A 1 -specific antigen) 3) and H-on-A (A 2 -specific antigen) 4) , which bind strongly to E-selectin, 5) are accumulated in various human cancers, 6 ) and provide a basis for tumor cell metastasis.
7) It was expected that SLe x epitope might also play a role in neutrophil recruitment during inflammatory response. Surprisingly, however, neither SLe x nor sialyl-dimeric Le x are found in human neutrophils or myelogenous leukemia HL60 cells -rather, these cells highly express unbranched, long-chain polylactosamines having terminal 2-3 sialylation and internal fucosylation. e  n  i  s  o  h  c  y  s  p  o  l  a  m  s  a  l  p  -6  ,  4   s  l  l  e  c  l  a  n  o  r  u  e  n  r  o  f  r  e  c  u  d  n  i  n  o  i  t  a  i  t  n  e  r  e  f  f  i  D   Table I . Novel GSL structures established by our research group Disialyl-Lc 4 Cer, defined by mAb FH9, 10) was originally found in colorectal cancer. Its related structure β1-4GalNAc-disialyl-Lc 4 Cer, defined by mAb RM2, 11) was originally found as renal cell carcinoma-associated antigen. We found recently that RM2 antigen is expressed highly in prostate cancer, but not in benign prostate hypertrophy or normal prostate tissue.
12)
Novel cationic GSLs having plasmal (myristal or palmital) conjugated with psychosine through 4,6 or 3,4 cyclic acetal linkage were found in brain white matter, and termed "plasmalopsychosine". 4,6-plasmalopsychosine displayed strong neurotrophic effect through activation of tyrosine kinase associated with Trk A (NGF receptor), and consequent long-term activation of Erk, inducing neuritogenesis. 13) GSL structures, and their changes associated with biological functions, have been the central focus of our studies, since structural change is the starting point for understanding biological significance, and enzymatic/ genetic mechanisms.
Functional interaction of GSLs through GSLenriched microdomain. During the 1980s and 1990s, the following lines of study evolved on functional roles of GSLs, as summarized in Fig. 1 . These studies were greatly accelerated by application of monoclonal antibody (mAb) approach and by cloning of key glycosyltransferase genes. (i) GSLs were identified as cell typespecific, developmentally-regulated antigens, as well as tumor-associated antigens, suggesting that they play essential roles in defining differentiation, development, and oncogenesis 14) -although target molecules with which GSLs interact during these processes have not been clearly identified.
(ii) GSLs were identified as receptors for bacterial toxins, or shown to mediate Cell adhesion is mediated through interaction of GSLs in interfacing microdomains (Process 6). GSLs interact with signal transducers in microdomains to initiate signal pathways (Process 7). Target molecules in Processes 2 through 7 are clear. However, various GSLs that display dramatic changes during ontogenic development or oncogenic transformation may interact with different target molecules at different stages of development or transformation to change cellular phenotype (Process 1). In most of these cases, the target molecule has not been identified. Recent studies indicate that GSL functions, categorized as 1 through 7 in Fig. 1 , are based on interaction with specific target molecules present within a certain type of GSL-enriched microdomain (GEM) (see below).
The cell surface membrane does not consist of homogeneous lipid bilayer as proposed in the classic Singer/Nicolson model. 21) Rather, it may have multiple, physically-distinguishable "plates" constituted by phospholipids having fatty acids with different degrees of unsaturation. 22) It was further proposed that plates consisting of sphingolipid may be distinguishable from those consisting of phospholipid, since sphingolipid has CONH or OH group which provides hydrogen bond donor as well as acceptor, whereas phospholipid has no such group and acts only as hydrogen bond acceptor. 23) These ideas were based on conformations of sphingolipid structures, but no clear supporting data from cell membranes were available. The concept that plasma membrane consists of heterogeneous GSL assemblies was first introduced as an "annular model" of GSLs. 24) , 25) According to this model, GSLs are arranged in annular (ring-like) fashion surrounding micropores or membrane proteins. 25) We found originally that GSLs are enriched at cell adhesion sites as detergent-insoluble form, termed "detergent-insoluble matrix (DIM)". 26) This is assumed to correspond to clustered form of GSL, as observed by scanning electron microscopy of "freeze-fractured" cell surface membrane, 27) or of GSL-phospholipid liposome membrane without cholesterol.
28)
Based on these and many other studies, the microdomain concept has developed slowly but steadily during the past 20 years. It was greatly advanced by analysis of caveolae or caveolar membrane, 29) proposal of "lipid raft", 30) and detailed documentation of physical properties of "detergent-resistant membrane (DRM)". 31) Some GEM display properties similar to those of lipid raft or "caveolar membrane", which are regarded as constantly-moving, signaling platforms involved in endo-or exocytosis, but not involved in cell adhesion, and are characterized by: (i) high dependence on cholesterol, i.e., disruption by cholesterol-binding reagent; (ii) resistance to 1% Triton X-100. The diameter of lipid raft was estimated as 50-100 nm, sometimes as small as 10 nm.
32), 33) In contrast, other types of GEM involved in GSLdependent or GSL-modulated cell adhesion and cell growth, particularly those highly enriched in PL/TSP, are distinguishable from lipid raft or caveolar membrane since they are independent of cholesterol but are nonresistant to (soluble in) 1% Triton X-100. Such GEM, are termed "glycosynapses" 17),34) (see Fig. 2A ), in analogy to "immunological synapse" that controls immunocyte adhesion to T-cell receptor, and antigen presentation. 35 ),36) GSL clusters at adhesion site, corresponding to glycosynapses, can be seen by light microscopy with fluorescent immunostaining, and their size is at least 1 µm. Contrasting properties of lipid rafts vs. glycosynapses are summarized in Table II . Our recent studies suggest that glycosynapses control adhesion-dependent cell growth, differentiation, and development, as well as oncogenic transformation and reversion (see "Expression of oncogenic phenotype, and its reversion...", p. 198).
GSLs as tumor-associated, and developmentally-regulated, antigens (Process 1 in Fig. 1 ). Tumor-associated antigens. Tumor cells are generally characterized by (i) down-regulated expression, or depletion, of a defined GSL, and (ii) accumulation of a defined GSL, recognized as a "tumor-associated antigen". The process (ii) results from precursor accumulation or activation of neosynthesis. 41) Our original studies on accumulation of Le x pentasaccharide Cer, 42) dimeric or trimeric Le x in colorectal cancer, 43) and Gg3 in KIMSV tumors in Balb/c mice, 44) were subsequently extended using the mAb approach. This led to discovery of many tumor-associated GSL antigens, e.g., Gb3 in Burkitt lymphoma 45) ; GD3 in melanoma 46) ; sialyl-Le x and sialyl-dimeric-Le ; and β4GalNAc disialyl-Lc 4 in renal cell cancer.
11) These and other antigens have been utilized for diagnosis and treatment of human cancers. Of special interest, immunization with synthetic globo-H/ KLH conjugate significantly suppressed prostate cancer progression. 49) This research area has been reviewed repeatedly (e.g., Refs. 50, 51). Developmentally-regulated GSL antigens. The process of development consists of a series of stage-specific cell adhesion events, which may generate signaling to define phenotypic change. In mouse embryogenesis, the first adhesion event, termed "compaction", is mediated by cooperative effect between Le x -to-Le x interaction 52), 53) and E-cadherin. 54) A model of compaction was provided by autoaggregation of mouse teratocarcinoma F9 cells, which is also mediated by cooperative effect between Le x and E-cadherin. 55) Mice with knockout of Ecadherin alone, 56) or FucT-IX alone, 57) exhibit normal compaction. FucT-IX may control synthesis of stage-specific embryonic antigen-1 (SSEA-1), which is Le x carried by long-chain poly-LacNAc. 58) Other types of Le x (carried by short-chain or branched-chain LacNAc) are not controlled by FucT-IX, rather by FucT-IV. Therefore, compaction may not be blocked unless the three genes for FucT-IV, -IX, and E-cadherin are knocked out simultaneously. . GEM containing high level of PL / TSP, involved in GSL-mediated cell adhesion, is termed "glycosynapse", and is distinguishable from moving, signaling platform ("raft") (see text). Cell adhesion through GSL-to-GSL interaction at GEM occurs in synergy with adhesion process based on interaction of integrin (I) with extracellular adhesive protein (Ap) such as FN or LN, 96) or on sugar-binding protein (S).
In primates (and presumably humans), compaction may be mediated by Gb4 and SSEA-3/4 (extended globo) in cooperation with E-cadherin, based on studies of the mechanism for autoaggregation of human teratocarcinoma 2102 or TERA-2. Several lines of evidence indicate that 2102 autoaggregation, mediated by Gb4, Gb5, and nLc 4 , induces signaling to activate transcription factors AP-1 and CREB. 59) Roles of GSLs in later stages of cell adhesion and development have not been studied. In GlcCer synthase gene (Ugcg gene) knockout mouse, embryogenesis proceeded normally until formation of primitive germ layers, but further development into mesoderm, endoderm, and ectoderm was halted, 60) indicating an essential role of GSLs in developmental processes. Fig.  1 ). Our group has made little contribution in this area, except for our (i) identification of Shigella toxin receptor as Gb3, in collaboration with G.T. Keusch's group, 63) and
GSLs as microbial receptors (Process 2 in
(ii) characterization of receptor for E. coli infection in urogenital epithelia as 2-3 sialyl-Gb5, in collaboration with A. Stapleton and W. E. Stamm. Sialyl-Gb5 is expressed only in blood group A/B non-secretor urogenital epithelia. 64) Secretor urogenital epithelia express globo-A or -B (Table I) . Three clinical isolates of pathogenic E. coli, having different types of "adhesin", showed consistently higher binding affinity to 2-3 sialylGb5 (SGb5) than to other globo-series structures (Figs.  3A, B ). This provides a rationale for the finding that nonsecretor women have much higher incidence of recurrent E. coli infection than secretors. E. coli infectivity to vaginal epithelial cells was abolished by treatment of cells with PDMP, which greatly suppresses synthesis of all GSLs. Interestingly, carrying of A/B epitope by globoseries structure is unique to urogenital epithelia. In other types of epithelia (bronchopulmonary, gastrointestinal, salivary), A/B epitope is carried by lacto-series structure.
Ganglioside effect on GFR function (Process 3 in Fig. 1 Fig. 3 . Globo-series structures as receptors for E. coli infection in urogenital epithelia. Panel A: The infection process depends on types of "adhesin", at fimbriae of E. coli, that bind to host cell GSLs. Blood group non-secretor women have a high rate of recurrent E. coli infection at urogenital epithelia, causing urethritis or cystitis. Such infection is based on the binding ability of E. coli to 2-3 sialyl-Gb5 (SGb5) expressed at urogenital epithelia. Three pathogenic E. coli clinical isolates (R45, 1A2, JJ122) showed higher binding affinity to SGb5 than to other globo-series structures. This property is common to all pathogenic isolates. Panel B: Globo-series GSLs expressed in secretor vs. non-secretor epithelia. In secretor women, GalGb4 (Gb5) is converted to globo-H, which is further converted to blood group globo-A or globo-B present in urogenital secretions (left). In contrast, in nonsecretor women, GalGb4 is converted to SGb5 or DSGb5, which are targets of E. coli infection (right). Results of a collaborative study with A. Stapleton 68) and FGFR tyrosine phosphorylation 39) are inhibited by GM3, whereas FGFR tyrosine phosphorylation in transformed cells is not inhibited by GM3. 39) Similarly, EGF-dependent tyrosine phosphorylation is inhibited by GM3. 69) In contrast, PDGF-induced tyrosine phosphorylation and cell growth are not inhibited by GM3, but are inhibited by gangliosides with more complex structures, such as GM1, GD1a, GD1b, and GT1b.
70),71)
The major question remains: how do gangliosides inhibit receptor-associated tyrosine kinase? The wellaccepted hypothesis is that receptor-associated kinase is activated through receptor-to-receptor interaction that occurs upon ligand binding. 72) A reasonable assumption is that GM3 may inhibit such interaction. However, quantitative inhibition of receptor-to-receptor dimer formation by GM3 is not clear. 73) Results of such experiments depend greatly on quality of antibody to detect such dimer. Further studies are necessary. Two factors modulate the effect of GM3 on EGF function. One is TSP (e.g., CD9, CD81), which promotes the inhibitory effect of GM3 on FGFR. 39) Similarly, CD82 mediates interaction of ganglioside GD1a with EGFR, thereby inhibiting EGF-induced signaling. 74) These findings indicate that association of GFR with GSL clusters in GEM is promoted by TSP displaying PL properties (Fig. 4A) . The other factor is N-glycosylation status of the receptor, as indicated by inhibition of binding of fluorescent "GM3 nanospheres" to EGFR at the cell surface when receptor N-glycosylation was blocked by tunicamycin. 75) EGFR tyrosine kinase activity in A431 cells was significantly reduced when cells were treated with N-glycosylation processing inhibitor Nmethyl deoxynojirimycin or swainsonine, suggesting that conversion from high-mannose-type to complextype receptor may inhibit interaction of GM3 with EGFR (Hikita, T., Handa, K., Hakomori, S., unpubl. data).
Insulin-dependent cell growth in human lymphoid cell line IM9, and in promyelocytic leukemia cell line HL60 was inhibited strongly by 2-3 sialylparagloboside, weakly by GM3, and was not affected by 2-6 sialylparagloboside. The degree of cell growth inhibition was correlated with inhibition of tyrosine kinase associated with insulin receptor. 76) Mouse mammary carcinoma mutant cells FUA169 contain high level of GM3, whereas parental F28-7 cells contain high LacCer and no GM3. F28-7 cells display strong insulin-dependent cell growth, whereas FUA169 do not. GM3 strongly inhibited insulin-dependent growth of F28-7 cells. 77) GM3 in mice, therefore, may regulate insulin-dependent metabolism. In fact, recent studies show that GM3 knockout mice display various symptoms of type 2 diabetes, due to loss of insulin resistance. 78) Similarly, GM3 is accumulated in 3T3-L1 adipocytes when TNFα is added, whereby insulin resistance is induced. Fig. 1) . Types of integrin subunit α/β combination define cellular interaction with ECM components. 80),81) Recent studies have revealed a few additional factors that promote or inhibit integrin-mediated adhesion and motility: (i) various types of TSP (some TSP display PL properties); (ii) gangliosides that mediate interaction of integrin with PL / TSP; (iii) N-glycosylation status of integrin and TSP. These factors are organized to form ganglioside/ integrin / TSP complex that mediates inhibition of cell motility and concurrent signaling (Fig. 4B) . TSPs CD9 and CD82 as motility-inhibitory factors. In studies using motility-inhibitory mAbs, we found a few factors controlling cell motility. One was H and /or Le y epitope 82) ; another was motility-regulatory protein-1 (MRP-1), having the same sequence as previously-known lymphocyte-differentiation factor CD9. 83) CD82 ("KAI-1") was originally discovered as antimetastasis gene product based on subtraction of mRNA of high-vs. low-metastatic tumor. 84) Both CD9 and CD82 were characterized as typical TSP having four transmembrane regions. Expression of both TSPs was down-regulated in metastatic deposits of various cancers, e.g., Ref. 85 . In many cases, their expression was inversely correlated with patient survival rate, e.g., Ref.
79)

Ganglioside effect on integrins and their complex with PL/TSP (Processes 4 and 5 in
86.
Ganglioside (particularly GM3), and N-glycosylation, are required for TSP/integrin-mediated motility-inhibitory effect. Surprisingly, the motilityinhibitory effect of CD9 and CD82 was not observed unless GM3 synthesis did not occur, or N-glycosylation was complete, as demonstrated in ldlD cells transfected with CD9 or CD82. ldlD cells are a UDP-Gal 4-epimerase-defective mutant, incapable of synthesizing GM3 or of complete N-glycosylation unless Gal is added to specific serum-free medium. 87) In many cases, interaction of TSP with integrin activates adhesion and motility (e.g., Ref. 88). However, α3/ CD9 interaction inhibits laminin-induced cell motility. This inhibitory effect requires the presence of GM3, and presumably Nglycosylation of α3.
38) The role of GM3 as co-factor of CD9 function was also demonstrated in various colorectal cancer cell lines with or without CD9 transfection. This concept was verified by direct interaction of photoactivatable GM3 with CD9 -but not with integrins α3, α5, α6, or β1.
89)
The important role of N-glycans in integrin function is indicated by a series of studies by N. Taniguchi and colleagues. The GlcNAcβ 1-6Manα 6 side chain (which depends on GlcNAc T-V) enhances integrin-dependent cell motility, whereas bisecting GlcNAcβ 1-4Man (which depends on GlcNAc T-III) inhibits such motility (for review see Ref. 90 ).
Effect of GSL on "cross-talk" between FGFR and TSP/integrin α3β1 (Processes 3, 4, and 5 in Fig. 1 ). Functional interaction ("cross-talk") of integrins with GFRs has become increasingly clear as a basic mechanism in cell biology, defining cell growth, adhesion, and motility. 91) Our recent studies indicate that cross-talk of FGFR with α3β1 or α5β1 in WI38 cells is strongly influenced by GM3 and TSP. GM3 depletion by P4 enhanced signaling by FGFR and Akt, and enhanced co-IP of FGFR with integrins. LN5-or FN-dependent proliferation of WI38 was enhanced by GM3 depletion, and by CD9/ CD81 co-knockdown by siRNA. 40) Thus, integrin-FGFR cross-talk is inhibited by GM3 and/or TSPs within GEM. Cell adhesion with concurrent signaling to affect cellular phenotype, through GSL-to-GSL interaction based on glycosynapses (Processes 6 and 7 in Fig. 1) . The basic mechanism of cell-to-cell adhesion is through (i) protein-to-protein interaction, e.g., between Ig adhesion receptors, cadherins, and ECM / integrins; (ii) carbohydrate-to-protein interaction, e.g., selectins, siglecs, galectins, and perhaps many other carbohydrate-binding proteins; (iii) carbohydrate-to-carbohydrate interaction (CCI), particularly well-established for GSL-to-GSL interaction from our studies, and for multiple oligosaccharides assembled in proteoglycans for species-specific sponge cell adhe-sion. 92) Specific carbohydrate structures known to be involved in cell recognition through CCI are limited at this time. Exact affinities and atomic forces acting between them have been elaborated in detail in recent studies (for review see Ref. 18 ). Many lines of evidence indicate that cell adhesion / recognition based on GSL-to-GSL interaction takes place through GEM containing chloroform/methanol-soluble PL such as CD9, as well as various signal transducer molecules as described above. We hypothesize that some tumor cells, or cells at defined stages of development, adhere together through glycosynapse 1, leading to activation of signal transducers to enhance cell growth, motility, and / or invasiveness (Fig. 2B) . 19 ), 20) Another type of adhesion system was found in which mucin-type glycans play an essential role in cell adhesion through a microdomain termed "glycosynapse 2". 17),93) A third adhesion system was found more recently in which ganglioside, particularly GM3, modulates cell adhesion and motility through CD9 (or CD82) / integrin complex. Such microdomain is termed "glycosynapse 3". 17),20),38)-40) These glycosynapse complexes are dissociated and solubilized in 1% Triton X-100. However, the complexes are maintained in 1% Brij 98, and are resistant to cholesterol-binding reagent. Glycosynapse 3 is involved in cell-to-cell or cell-to-ECM adhesion, and is relatively stationary. These properties are distinctive from those of moving, signaling platform ("lipid raft"), which is insoluble in 1% Triton X-100 but disrupted by cholesterol-binding reagent (see Table II ). Expression of oncogenic phenotype, and its reversion, by depletion or enhancement of GM3 synthesis in glycosynapse 3. Jun-induced oncogenic phenotypes in C3H mouse fibroblast 10T1/2 and chicken fibroblast DF1 cell lines have been well-established, as enhanced cell growth and colony formation in soft agar. Numerous changes of gene expression induced by Jun are known. However, on a membrane molecular level, GM3 is down-regulated or depleted in both mouse and chicken fibroblasts. Transfection of GM3 synthase gene to increase GM3 level in these transformants interferes with or blocks expression of transformed phenotype; i.e., oncogenic phenotype is "reverted" to normal phenotype. Membrane organization in terms of CD9/α 5 or CD9/β 1 interaction is thereby significantly enhanced. 94) Haptotactic motility of various colorectal cancer cell lines (SW480, SW620, HRT18) having high CD9 level was strongly suppressed by exogenous GM3 addition. In contrast, motility of gastric cancer cell line MKN74 having low CD9 level was not affected by GM3 addition.
When CD9 was increased in MKN74 through gene transfection, motility was suppressed by GM3 addition. 89) Similarly, motility of highly-invasive bladder cancer cell line YTS-1, having low GM3 but high CD9 level, was strongly suppressed by brefeldin A-induced enhancement of GM3 synthesis. Bladder cancer cell line KK47, having high GM3 and high CD9 level, is not invasive. 95) Thus, reversion from invasive / malignant phenotype to nearly-normal phenotype is possible through increase of GM3 and CD9 in glycosynapse 3 of bladder cancer cells. Conversion from non-malignant to highly-malignant phenotype is possible through decrease of GM3 (Mitsuzuka, K., Handa, K., Hakomori, S., unpubl. data). The process of oncogenic transformation, and its reversion, can be correlated with levels of GM3, PL / TSP, and integrin receptor, as shown schematically in Fig. 5 . Conclusion and perspectives. Our initial, major effort in GSL studies was characterization of structures, and their changes during ontogenic development and oncogenic transformation. We identified many GSLs as antigens or receptors. We also identified gangliosides, particularly GM3, as modulators of cell growth, or of cellto-cell or cell-to-ECM interaction. Some of the target molecules with which GSLs interact, such as GFRs (with PL/TSP), and integrins (with PL/TSP), have been identified. However, target molecules of many tumorassociated GSL antigens, and of GSLs that show changes during development or transformation, remain to be studied.
Some types of GEM function as moving, signaling platforms characteristic of "raft", while others are involved in integrin / TSP-dependent cell adhesion or GFR/TSP-dependent cell growth. Functional interaction ("cross-talk") between integrin and GFR, mediated by GM3/TSP complex within microdomain, was clarified recently. 40) There may be many other microdomains, depending on type of cell and location within cell. Cross-talk between rafts, glycosynapses, and other microdomains is an important topic for future study, since many functions of GSLs are based on their interaction with key membrane molecules at respective microdomains. These studies will clarify the mechanism by which GSLs control differentiation, development, oncogenesis, and apoptosis. Much commentary has been directed to tumorassociated antigens and their functional concepts. Reversion from transformed to normal cell phenotype, and conversion from normal to transformed phenotype, reflects ganglioside-dependent stability or its loss in glycosynapse 3. A wide variety of other diseases such as diabetes, inflammatory processes, and infection have been explained in terms of structure, composition, and organization of microdomains (including glycosynapses). Further studies along this line will not only clarify the role of GSLs, but also reveal secrets of various disease processes.
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